Molecular Partners AG (SWX: MOLN)
Switzerland
· Delayed Price · Currency is CHF
4.430
+0.370 (9.11%)
Jan 3, 2025, 5:31 PM CET
Molecular Partners AG Employees
Molecular Partners AG had 168 employees as of December 31, 2023. The number of employees decreased by 8 or -4.45% compared to the previous year.
Employees
168
Change (1Y)
-8
Growth (1Y)
-4.45%
Revenue / Employee
35.73K CHF
Profits / Employee
-372.57K CHF
Market Cap
163.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,605 |
Novartis AG | 76,057 |
Lonza Group AG | 18,000 |
Alcon | 25,315 |
Galderma Group AG | 6,545 |
Straumann Holding AG | 11,109 |
Sonova Holding AG | 18,151 |
Sandoz Group AG | 22,633 |
Molecular Partners AG News
- 18 days ago - Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January - GlobeNewsWire
- 27 days ago - Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024 - GlobeNewsWire
- 2 months ago - Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024 - GlobeNewsWire
- 2 months ago - Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going - GlobeNewsWire
- 2 months ago - Molecular Partners prices $20M offering - Seeking Alpha
- 2 months ago - Molecular Partners Announces Pricing of $20 Million Underwritten Offering - GlobeNewsWire
- 2 months ago - Molecular Partners stock climbs 6% on expanded radiopharmaceuticals deal - Seeking Alpha
- 2 months ago - Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024 - GlobeNewsWire